PMA supplement
P040002 S073: AFX2 Endovascular AAA System
FDA PMA supplement · Real-Time Process · Endologix, LLC
Key facts
| Original PMA | P040002 |
|---|---|
| Supplement number | S073 |
| Supplement type | Real-Time Process |
| Reason for the supplement | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| Trade name | AFX2 Endovascular AAA System |
| Generic name | SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT |
| Applicant | Endologix, LLC |
| Product code | MIH |
| Received date | May 24, 2024 |
| Decision date | Aug 22, 2024 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: